go back

Indium In-111 Ibritumomab Tiuxetan, Diagnostic

Tennessee rates for HCPCS A9542

Indium In-111 ibritumomab tiuxetan, diagnostic, per study dose, up to 5 mCi

Rates data updated July 2026.

Facilitymedian $4,169 · 10th–90th $2,399$23,9880%20%10th90th$4,169Professionalmedian $2,818 · 10th–90th $2,138$3,6310%20%10th90th$2,818$2.0K$5.0K$10.0K$20.0K

Distribution of negotiated rates across all payers (price axis is log-scale). Facility and professional rates are different services and are charted separately. Need provider-level prices? Contact us.

Insurance Carrier
Aetna
Setting
Facility
Modifier
Global
Typical Low
$2,398.83
Median
$2,818.38
Typical High
$3,715.35
Aetna
Setting
Professional
Modifier
Global
Typical Low
$2,137.96
Median
$2,630.27
Typical High
$3,630.78
Cigna
Setting
Facility
Modifier
Global
Typical Low
$3,548.13
Median
$4,897.79
Typical High
$5,754.40
Cigna
Setting
Professional
Modifier
Global
Typical Low
$3,548.13
Median
$3,548.13
Typical High
$3,548.13
Lucent Health
Setting
Facility
Modifier
Global
Typical Low
$23,988.33
Median
$23,988.33
Typical High
$23,988.33
Lucent Health
Setting
Professional
Modifier
Global
Typical Low
$23,988.33
Median
$34,673.69
Typical High
$34,673.69
United
Setting
Facility
Modifier
Global
Typical Low
$6,760.83
Median
$8,912.51
Typical High
$8,912.51
United
Setting
Professional
Modifier
Global
Typical Low
$3,981.07
Median
$4,168.69
Typical High
$4,168.69